S. Ito
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
S. Ito has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
A. Hachiya
Kao Corporation, Tochigi, Japan
1 shared publicationA. Naoe
Kao Corporation, Tochigi, Japan
1 shared publicationH. Yoshida
Kao Corporation, Tochigi, Japan
1 shared publicationJ. Ishikawa
Kao Corporation, Tochigi, Japan
1 shared publicationT. Fujimura
Kao Corporation, Tochigi, Japan
1 shared publicationT. Kitahara
Kao Corporation, Tochigi, Japan
1 shared publication
Latest Publications
- 29 June 2016
- Published by Wiley in Journal of the European Academy of Dermatology and Venereology
- Vol. 31 (1) , 135-141
Ceramide synthase 4 is highly expressed in involved skin of patients with atopic dermatitis
Background: Ceramide is a crucial lipid in the stratum corneum (SC) which maintains the barrier function and hydration of the skin. In atopic dermatitis (AD) patients who have defective skin barrier function, ceramide levels are altered. We previously reported that although the amount of total ceramide was lower in involved skin compared with uninvolved skin of AD patients and with healthy control skin, the amounts of smaller ceramide species of Cer[NS] (P < 0.01). Additionally, the protein expression level of CERS4 in the epidermis was also higher in involved skin compared with uninvolved skin. The expression level of CERS4 correlated with the amount of C34‐Cer[NS] (P < 0.01) and the skin hydration value (P < 0.05).Conclusions: The elevated expression level of CERS4 contributes to the increase of C34‐Cer[NS] and the impaired SC barrier function in involved skin of AD patients.
- 29 June 2016
- Published by Wiley in Journal of the European Academy of Dermatology and Venereology
- Vol. 31 (1) , 135-141
Ceramide synthase 4 is highly expressed in involved skin of patients with atopic dermatitis
Background: Ceramide is a crucial lipid in the stratum corneum (SC) which maintains the barrier function and hydration of the skin. In atopic dermatitis (AD) patients who have defective skin barrier function, ceramide levels are altered. We previously reported that although the amount of total ceramide was lower in involved skin compared with uninvolved skin of AD patients and with healthy control skin, the amounts of smaller ceramide species of Cer[NS] (P < 0.01). Additionally, the protein expression level of CERS4 in the epidermis was also higher in involved skin compared with uninvolved skin. The expression level of CERS4 correlated with the amount of C34‐Cer[NS] (P < 0.01) and the skin hydration value (P < 0.05).Conclusions: The elevated expression level of CERS4 contributes to the increase of C34‐Cer[NS] and the impaired SC barrier function in involved skin of AD patients.